InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（3 笔）
内部人交易记录
其他已披露买入
2
已披露卖出
3
T+90 胜率
100%
T+90 平均收益
+74.2%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the full record of transactions filed by Boyd Peter E., See Remarks. Director active across 1 company, notably Aquestive Therapeutics, Inc.. Aggregated, 12 disclosures have been logged. Breakdown: 2 buys · 3 sells. Total volume traded: €188k. Activity tracked since 8 June 2022. The latest transaction was disclosed on 9 September 2026 (X). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Boyd Peter E.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
2,293 股@ US$0.96Common StockSEC:0001214659-26-011541:0
80,000 股0Common StockSEC:0001214659-26-003147:0
20,000 股0Common StockSEC:0001214659-25-017652:0
10,000 股@ US$7.000.013% mcap16.2% 占其流量Common StockSEC:0001214659-25-015046:0
10,000 股@ US$6.300.012% mcap14.6% 占其流量Common StockSEC:0001214659-25-014287:0
15,000 股@ US$5.300.015% mcap18.4% 占其流量Common StockSEC:0001214659-25-013485:0
80,000 股0Common StockSEC:0001214659-25-004222:0
8,370 股@ US$4.889.1% 占其流量Common StockSEC:0001214659-24-004394:0
86,250 股0Common StockSEC:0001214659-24-004303:0
100,000 股0Common StockSEC:0001214659-23-003695:0
5,000 股@ US$0.811.7% 占其流量Common StockSEC:0001628280-22-017186:0
标准退出：2022年9月12日 (T+90)
2,293 股@ US$0.960.9% 占其流量Common StockSEC:0001628280-22-016872:0
标准退出：2022年9月6日 (T+90)
12 条申报中的 12 条
About Boyd Peter E.
Boyd Peter E. is associated with Aquestive Therapeutics, Inc. as Chief People Officer. He has 11 filings in total, and across the 11 sampled filings the activity runs from 2022-06-10 to 2026-03-11, with 5,933 EUR of buys and 182,323 EUR of sells, and the modal transaction nature is Attribution.
